NovoCure Ltd Insider Trading Activity
Every SEC Form 4 insider transaction reported for NovoCure Ltd (NVCR), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are NVCR insiders buying or selling?
In the last 12 months, NovoCure Ltd insiders reported 0 open-market purchases ($0) and 12 sales ($1.4M) — net selling of $1.4M. Since January 2018, Trabud has recorded 351 Form 4 filings for NVCR: 3 buys ($1.7M) and 348 sells ($528.1M).
Source: SEC EDGAR Form 4
What stands out
- No NovoCure Ltd insider made an open-market purchase in the last 12 months; the 12 reported open-market sales totaled $1.4M.
Key Statistics (January 2018 – Jun 5, 2026)
Total Form 4 filings
351
SEC EDGAR
Insider filers
26
Insider buys (3)
$1.7M
Insider sells (348)
$528.1M
Insider sentiment
Net sellingNet insider flow of $526.4M in net selling since January 2018, and $1.4M in net selling over the last 12 months.
Recent NVCR insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Frank X Leonard | Chief Executive Officer | Sale | 34.3K | $17.93 | $614.6K | SEC ↗ |
| Jun 3, 2026 | Gabriel Leung | Director | Sale | 2.9K | $15.77 | $46.4K | SEC ↗ |
| Jun 3, 2026 | Kristin Stafford | Director | Sale | 2.9K | $15.77 | $46.4K | SEC ↗ |
| Jun 3, 2026 | Allyson J Ocean | Director | Sale | 2.9K | $15.77 | $46.4K | SEC ↗ |
| Jun 3, 2026 | Timothy J Scannell | Director | Sale | 2.9K | $15.77 | $46.4K | SEC ↗ |
| Jun 3, 2026 | Jeryl L Hilleman | Director | Sale | 2.9K | $15.77 | $46.4K | SEC ↗ |
| Jun 3, 2026 | Anthony W Vernon | Director | Sale | 2.9K | $15.77 | $46.4K | SEC ↗ |
| Jun 3, 2026 | Hung David | Director | Sale | 2.9K | $15.77 | $46.4K | SEC ↗ |
| Mar 5, 2026 | Nicolas Leupin | Former Chief Medical Officer | Sale | 1.1K | $13.31 | $14.6K | SEC ↗ |
| Mar 3, 2026 | Uri Weinberg | Chf Medical and Innovation Ofr | Sale | 10.7K | $13.68 | $146.9K | SEC ↗ |
| Mar 3, 2026 | Michal Nath Puri | Chief Human Resources Officer | Sale | 1.4K | $13.66 | $19.7K | SEC ↗ |
| Mar 3, 2026 | Frank X Leonard | Chief Executive Officer | Sale | 17.0K | $13.59 | $230.6K | SEC ↗ |
| Sep 8, 2025 | Ashley Cordova | Chief Executive Officer | Purchase | 81.5K | $12.22 | $996.9K | SEC ↗ |
| Jul 30, 2025 | Christoph Brackmann | Chief Financial Officer | Purchase | 20.0K | $11.59 | $231.8K | SEC ↗ |
| Jun 4, 2025 | Kristin Stafford | Director | Sale | 999 | $17.28 | $17.3K | SEC ↗ |
| Jun 4, 2025 | Gabriel Leung | Director | Sale | 999 | $17.31 | $17.3K | SEC ↗ |
| Jun 4, 2025 | Martin J. Madden | Director | Sale | 999 | $17.19 | $17.2K | SEC ↗ |
| Jun 4, 2025 | Timothy J Scannell | Director | Sale | 999 | $17.32 | $17.3K | SEC ↗ |
| Jun 4, 2025 | Jeryl L Hilleman | Director | Sale | 999 | $17.26 | $17.2K | SEC ↗ |
| Jun 4, 2025 | Allyson J Ocean | Director | Sale | 999 | $17.29 | $17.3K | SEC ↗ |
| Jun 4, 2025 | Anthony W Vernon | Director | Sale | 999 | $17.35 | $17.3K | SEC ↗ |
| Jun 4, 2025 | Hung David | Director | Sale | 999 | $17.30 | $17.3K | SEC ↗ |
| Jun 4, 2025 | Frank X Leonard | EVP, Pres., Novocure Oncology | Sale | 30.2K | $17.50 | $528.4K | SEC ↗ |
| May 5, 2025 | Mukund Paravasthu | Chief Operating Officer | Sale | 592 | $17.91 | $10.6K | SEC ↗ |
| Mar 4, 2025 | Uri Weinberg | Chief Innovation Officer | Sale | 268 | $18.92 | $5.1K | SEC ↗ |
Showing the 25 most recent of 351 Form 4 filings for NovoCure Ltd.
Most active NVCR insiders
- Wilhelmus CM Groenhuysen46 filings
- Pritesh Shah45 filings
- Gabriel Leung35 filings
- Frank X Leonard30 filings
- Asaf Danziger29 filings
Ask anything about NVCR insider activity
Use Trabud's AI agent to query NovoCure Ltd's Form 4 history in plain English — "Show me NVCR CEO purchases this year" or compare it against any other ticker.
Open the AI agentNVCR insider trading FAQ
Are NovoCure Ltd insiders buying or selling?
In the last 12 months, NovoCure Ltd insiders reported 0 open-market purchases ($0) and 12 sales ($1.4M) — net selling of $1.4M. Since January 2018, Trabud has recorded 351 Form 4 filings for NVCR: 3 buys ($1.7M) and 348 sells ($528.1M). Over the full record that is net selling of $526.4M.
How many insiders trade NVCR stock?
26 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for NovoCure Ltd. The most recent filing was accepted on Jun 5, 2026.
Where does Trabud get NVCR insider trading data?
All NVCR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.